[PDF] Top 20 Introducción a la dinámica del cuerpo rígido
Has 10000 "Introducción a la dinámica del cuerpo rígido" found on our website. Below are the top 20 most common "Introducción a la dinámica del cuerpo rígido".
Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
... from treatment with one drug alone may be given two or more drugs, which can be combined into one ...is glycopyrrolate (also referred to as glycopyrronium ...bromide). Glycopyrrolate can be used to ... See full document
38
Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease
... with chronic obstructive pulmonary disease (COPD) will increase, according to the progressively aging population and the increased efficacy of the pharmacological treatments, especially ... See full document
16
Aerosol Inhalation of Tanreqing Injection Combined with Conventional Western Medicine in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: a systematic review of Randomized Controlled Trials
... Chronic obstructive pulmonary disease (COPD) is a chronic, irreversible lung disease which is characterized by progressive deterioration of lung function ...Besides ... See full document
27
The efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methods
... 1. ‘momentasone’:ab, ti OR ‘ics’:ab, ti OR ‘inhaled corticosteroid’:ab, ti OR ‘budesonide’:ab, ti OR ‘glucocorticoids’:ab, ti OR ‘adrenal cortex hormones’:ab, ti OR ‘corticosteroids’:ab, ti OR ‘pulmicort’:ab, ti ... See full document
7
Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia
... There are a number of limitations to this study. First, we did not evaluate extrapulmonary side effects, such as osteoporosis severity or the development of cardiovascular events. Second, the airway pathophysiological ... See full document
18
Bacterial and Fungal Profile of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
... Study conducted by Iain B Gosbell et al stated that the prevalence of PRSP (Penicillin Resistant Streptococcus pneumoniae) was about 20% (100) . Emilio Perez – trallero et al. in their study stated that Streptococcus ... See full document
12
Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
... ICS treatment vs placebo ...between treatment groups at 36 ...with treatment, except for a slightly worse mental health subscale score at 36 months in the ICS group compared with ... See full document
6
High intensity versus low intensity noninvasive positive pressure ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease (HAPPEN): study protocol for a multicenter randomized controlled trial
... The HAPPEN study protocol has limitations which must be addressed. First, the study is being performed in patients with mild to moderate respiratory acidosis, which suggests that the results may not be generalizable to ... See full document
7
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment
... “chronic obstructive pulmonary disease” and “COPD” were searched for the disease, the terms “ LABAs ” and “ LAMAs ” for the class of drugs, the terms “ aclidinium ” , “ formoterol ” , “ ... See full document
15
<p>Status of and strategies for improving adherence to COPD treatment</p>
... to treatment by patients with chronic obstructive pulmonary disease (COPD) still present some ...of treatment adherence, compliance and ...measuring treatment adherence ... See full document
5
<p>Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD</p>
... severe chronic obstructive pulmonary disease (COPD) from Asia, Europe, and the ...µg, glycopyrrolate (GP) MDI 18 µg, formoterol fumarate (FF) MDI ...male). Treatment with GFF MDI ... See full document
12
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
... of inhaled budesonide remains heterogenous, and lim- ited to only seven RCTs and total sample size of nearly 40% of ...of inhaled budesonide exposure, which reduced the power of the budesonide analy- sis to ... See full document
6
Altered deposition of inhaled nanoparticles in subjects with chronic obstructive pulmonary disease
... respiratory disease. Respiratory disease was assessed with pulmonary function testing and, for subjects with previously diagnosed disease, computed tomography ...respiratory disease ... See full document
23
The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
... between inhaled corticosteroid (ICS) exposure patterns and the risk of pneumonia in chronic obstructive pulmonary disease (COPD) patients, we performed a nested case-control ... See full document
16
Toward effective prescription of inhaled corticosteroids in chronic airway disease
... COPD treatment goals are similar: improving symptoms (dyspnea), reducing the risk of acute exacerbations, and improving quality of ...non-drug treatment modalities are helpful to achieve optimal outcomes in ... See full document
5
Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
... for chronic Obstructive Lung Disease [GOLD] criteria with a postbronchodila- tor forced expiratory volume in 1 second (FEV 1 )/forced vital capacity (FVC) ... See full document
9
The dose of inhaled corticosteroids in patients with COPD: when less is better
... with obstructive lung disease in the UK, patients receiving daily ICS doses in excess of 700 µ g (fluticasone propionate equivalent) were significantly more likely (OR ... See full document
16
Outpatient pulmonary rehabilitation – rehabilitation models and shortcomings in outpatient aftercare
... of pulmonary rehabilitation like prevention and adequate treatment of acute exacerbations, the mini- misation of hospitalisation and the reduction of mortality are attained in out-patient as well as in ... See full document
507
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK
... relatively common for patients with no exacerbation history, or with low symptoms or protected lung function, to eventu- ally drift to TT, without being prescribed more appropriate therapies like dual bronchodilators. ... See full document
5
Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension
... end-stage pulmonary disease secondary to airway disease and pulmonary hypertension (with a mean pulmonary arterial pressure > 20 mmHg) who were evaluated for lung transplan- tation ... See full document
8
Related subjects